While using macrolides for the treatment of infectious diseases, some non-m
icrobiological effects have been observed. The stimulation of gastrointesti
nal motility, which is a common side-effect of macrolides, may be advantage
ous in patients with poor upper gut motility. Macrolides, as well as direct
ly inhibiting bacterial growth, may exert immunomodulatory effects. Utilisa
tion of these properties may be useful in the treatment of chronic inflamma
tory conditions, especially if bacterial infection is also implicated. Prel
iminary evidence also suggests that the currently available macrolide antib
iotics possess antitumour activity. In the future, an increased understandi
ng of the structure-activity relationships of macrolides may result in the
development of new structurally related compounds that concentrate on these
pharmacological properties in addition to, or instead of, antimicrobial ac
tivity. (C) 2001 Elsevier Science B.V. and International Society of Chemoth
erapy. All rights reserved.